Mass spectrometry method for screening protein with structure and interaction changes caused by drug

A technology for screening drugs and analysis methods, which is applied in the field of mass spectrometry analysis of proteins that cause structural and interaction changes caused by drugs. It can solve the problems of cross-linked mass spectrometry data processing difficulties and achieve the effect of reducing the difficulty of analysis.

Active Publication Date: 2020-03-10
DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But these methods usually need more stringent conditions, such as restriction proteolysis technology needs to strictly control enzymolysis conditions (document 2.Piazza I; Kochanowski K; Cappelletti V; et al.A Map of Protein-Metabolite InteractionsReveals Principles of Chemical Communication .Cell 2018, 172(1-2), 358-372), cross-linked mass spectrometry faces difficulties in data processing (document 3.Ferber M, Kosinski J, Ori A, et al.Automated structure modeling of large protein assemblies using crosslinks as distancerestraints.Nature methods,2016,13(6):515-520), the chemical proteomics technology based on active molecular probes needs to design and synthesize probes to make them accurately reach the protein binding region (document 4. Bachovchin D A, Brown S J, Rosen H, et al. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nature biotechnology, 2009, 27 (4): 387-394)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mass spectrometry method for screening protein with structure and interaction changes caused by drug
  • Mass spectrometry method for screening protein with structure and interaction changes caused by drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Screening of dasatinib-binding proteins in complex biological samples

[0023] Take K562 cells (10 7 ), lyse the cells in an active state to obtain a protein solution with a concentration of 1 μg / μL, and equally divide them into a control group and an experimental group, with 3 samples in each group. 25 μmol / L dasatinib was added to the experimental group, and both the control group and the experimental group were placed on a constant temperature shaker mixer at 25°C and incubated for 30 min. Add final concentration 10mmol / L to the above sample 13 cd 2 O and 20mmol / L NaBD 3The labeling reaction of CN in active state was carried out at 25°C for 30min. After the reaction, 5 times the volume of protein precipitation solution (ethanol / acetone / acetic acid=500 / 500 / 1, volume ratio) was quickly added, and precipitated overnight in a -20°C refrigerator. The precipitated protein was separated with a high-speed centrifuge at 4°C and 25,000 g, and dissolved with a final concen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a mass spectrometry method for rapidly screening a specific protein with structure and interaction changes caused by drug molecules from a complex cell or tissue lysed proteinsample. The mass spectrometry analysis method is specifically an activity-denaturation two-step stable isotope covalent chemical labeling method. In the two-step labeling, an isotope mass differencelabeling reagent is used, and the protein with the structure and interaction being changed by the drug molecules causes changes of the labeling efficiency of a change region in the first step of activity labeling process, so that the difference of isotope peaks is shown in a final mass spectrum quantitative result. The method provides a brand-new high-throughput mass spectrometry method for rapidly screening a target protein with structure and interaction changes caused by drug molecule binding in a complex system.

Description

technical field [0001] The invention belongs to the field of mass spectrometry analysis method for quickly screening proteins with changes in structure and interaction caused by drugs in complex systems, in particular to a method for quickly screening specific proteins with changes in structure and interaction caused by drug molecules from complex cell or tissue lysed protein samples new method of mass spectrometry. Background technique [0002] As the executor of life activities, protein almost participates in and controls all life activities in organisms. The combination of drugs and proteins will cause changes in the protein structure, how to effectively detect the interaction between drugs and proteins plays an important role in biochemical research and drug development. In recent years, the analysis method of drug-protein interaction based on mass spectrometry has been gradually developed. Compared with other techniques such as X-ray crystallography and nuclear magnet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N33/58G01N33/68
CPCG01N30/02G01N33/58G01N33/68
Inventor 王方军周烨刘哲益
Owner DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products